Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Shobana Kamineni,...

    Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

    Written by supriya kashyap kashyap Published On 2017-05-02T11:10:13+05:30  |  Updated On 2 May 2017 11:10 AM IST
    Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

    The Confederation of Indian Industry (CII) announced new office-bearers for the year 2017-18. Ms Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., has assumed office as the new President of CII. She takes over from Dr Naushad Forbes, Co-Chairman, Forbes Marshall Limited.


    Ms Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., (AHEL) has taken over as President, CII. AHEL is Asia’s foremost integrated healthcare organization. Ms Kamineni helms the Apollo Global Projects Consultancy, which steers the planning, design and execution of new projects. She also heads Apollo Pharmacy, presently the fastest growing business within AHEL.


    Kamineni, who is the third daughter of AHEL’s founder and chairman Dr Prathap Reddy, helms the Apollo Global Projects Consultancy, which steers the planning, design and execution of new projects at AHEL. Besides, she heads the Apollo Pharmacy business which constitutes 45 percent of AHEL’s turnover. Kamineni is also the vice-chairperson of the KEI Group, a diversified logistics, leisure and infrastructure company.


    In addition, Ms Kamineni is Vice-Chairperson of the KEI Group, a diversified logistics, leisure & infrastructure business. She is an active member of CII and has been a recipient of prestigious national awards for Entrepreneurship and Leadership.


    Ms Kamineni holds a B.A. in Economics from Stella Maris College, Chennai and an accelerated Diploma in Hospital Administration from Columbia University, New York.


    Mr Rakesh Bharti Mittal, Vice Chairman, Bharti Enterprises, is the new President Designate, CII. Bharti Enterprises is one of India’s leading business groups with interests in telecom, agri and food business, financial services, retail, realty, and communication & media devices.


    Mr Mittal is the Vice Chairman of Bharti Enterprises, Chairman of Bharti AXA Life Insurance, Bharti AXA General Insurance, FieldFresh Foods and Centum Learning. Mr Mittal is also a member of India – Canada CEOs Forum and India Pakistan Joint Business Forum (IPJBF) and several Government Committees and Governing Councils of Institutions of Excellence like ICAR.


    Mr Uday Kotak, Executive Vice Chairman and Managing Director, Kotak Mahindra Bank Limited is the new Vice President of CII. Mr Kotak has several awards to his credit and recently he won ET’s Business Leader of the Year award. Mr Kotak is the Co-Chair of the India-UK Financial Partnership (IUKFP) with Sir Gerry Grimstone as the other Co-Chair.


    Mr Kotak holds a Bachelor’s degree in Commerce and an MBA from Jamnalal Bajaj Institute of Management Studies, Mumbai.

    AHELApollo HospitalsApollo Hospitals Enterprise LimitedCIIDr Naushad ForbesDr Prathap ReddyShobana Kamineni
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok